Abstract

The present invention relates to a vaccine against hantavirus pulmonary syndrome (HPS), comprising recombinant polypeptides that allow immunity to be developed against the hantaviruses that cause HPS. Said recombinant polypeptides contain a specific antigenic fragment of the Gn and GC sequence of the Andes virus. The present invention also relates to the amino acid sequences of the recombinant polypeptides and to the nucleotide sequences coding same.